NDAQ:ACOG - Post Discussion
Post by
partystocker on Nov 04, 2021 11:26am
$ACOG getting some major recognition from analysts
Alpha Cognition Inc. $ACOG/$ACOG.V shares are recovering nicely from a small dip earlier this month.
$ACOG’s Alzheimer's drugs are getting some serious attention from analysts. In a recent statement, Chelsea Stellick of iA Capital Markets initiated a speculative buy rating for $ACOG with a price target of $5.00 per share. At current prices of $1.19 this equates to a 420% price increase.
$ACOG’s ALPHA-1062 Alzheimer's treatment is currently in a de-risked trial with strong data behind it. These trials also only require bioequivalence rather than efficacy. This article gives a great rundown of $ACOG’s current pharmaceutical lineup as well as some breakdown on revenue projections for their new products.
With prices trading at near recent lows, this could be a great time to scoop up some shares of $ACOG.
$ACOG is currently trading at $1.19 and is valued at $73.18M.
https://www.cantechletter.com/2021/10/alpha-cognition-could-have-a-best-in-class-alzheimers-drug-ia-capital-says/#
Be the first to comment on this post